These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11407897)

  • 1. Regulation of angiogenesis and matrix remodeling by localized, matrix-mediated antisense gene delivery.
    Kyriakides TR; Hartzel T; Huynh G; Bornstein P
    Mol Ther; 2001 Jun; 3(6):842-9. PubMed ID: 11407897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPARC-thrombospondin-2-double-null mice exhibit enhanced cutaneous wound healing and increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges.
    Puolakkainen PA; Bradshaw AD; Brekken RA; Reed MJ; Kyriakides T; Funk SE; Gooden MD; Vernon RB; Wight TN; Bornstein P; Sage EH
    J Histochem Cytochem; 2005 May; 53(5):571-81. PubMed ID: 15872050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice that lack the angiogenesis inhibitor, thrombospondin 2, mount an altered foreign body reaction characterized by increased vascularity.
    Kyriakides TR; Leach KJ; Hoffman AS; Ratner BD; Bornstein P
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4449-54. PubMed ID: 10200282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered extracellular matrix remodeling and angiogenesis in sponge granulomas of thrombospondin 2-null mice.
    Kyriakides TR; Zhu YH; Yang Z; Huynh G; Bornstein P
    Am J Pathol; 2001 Oct; 159(4):1255-62. PubMed ID: 11583953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombospondin 2-null mice display an altered brain foreign body response to polyvinyl alcohol sponge implants.
    Tian W; Kyriakides TR
    Biomed Mater; 2009 Feb; 4(1):015010. PubMed ID: 19020342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced angiogenesis characteristic of SPARC-null mice disappears with age.
    Reed MJ; Bradshaw AD; Shaw M; Sadoun E; Han N; Ferara N; Funk S; Puolakkainen P; Sage EH
    J Cell Physiol; 2005 Sep; 204(3):800-7. PubMed ID: 15795937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced foreign body reaction to implanted biomaterials by surface treatment with oriented osteopontin.
    Liu L; Chen G; Chao T; Ratner BD; Sage EH; Jiang S
    J Biomater Sci Polym Ed; 2008; 19(6):821-35. PubMed ID: 18534099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombospondin 2 levels are increased in aged mice: consequences for cutaneous wound healing and angiogenesis.
    Agah A; Kyriakides TR; Letrondo N; Björkblom B; Bornstein P
    Matrix Biol; 2004 Jan; 22(7):539-47. PubMed ID: 14996433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonviral vector loaded collagen sponges for sustained gene delivery in vitro and in vivo.
    Scherer F; Schillinger U; Putz U; Stemberger A; Plank C
    J Gene Med; 2002; 4(6):634-43. PubMed ID: 12439855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the foreign body response to implanted sensor models through device-based delivery of the tyrosine kinase inhibitor, masitinib.
    Avula MN; Rao AN; McGill LD; Grainger DW; Solzbacher F
    Biomaterials; 2013 Dec; 34(38):9737-46. PubMed ID: 24060424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular matrix scaffolds are repopulated by bone marrow-derived cells in a mouse model of achilles tendon reconstruction.
    Zantop T; Gilbert TW; Yoder MC; Badylak SF
    J Orthop Res; 2006 Jun; 24(6):1299-309. PubMed ID: 16649228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laminin-5-enriched extracellular matrix accelerates angiogenesis and neovascularization in association with ePTFE.
    Kidd KR; Williams SK
    J Biomed Mater Res A; 2004 May; 69(2):294-304. PubMed ID: 15058002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foreign body response to subcutaneous biomaterial implants in a mast cell-deficient Kit(w-Sh) murine model.
    Avula MN; Rao AN; McGill LD; Grainger DW; Solzbacher F
    Acta Biomater; 2014 May; 10(5):1856-63. PubMed ID: 24406200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury.
    Bornstein P; Agah A; Kyriakides TR
    Int J Biochem Cell Biol; 2004 Jun; 36(6):1115-25. PubMed ID: 15094126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implant-stimulated interface reactions during collagenous bone matrix-induced bone formation.
    Reddi AH
    J Biomed Mater Res; 1985 Mar; 19(3):233-9. PubMed ID: 4077882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine and chemokine dynamics differ between rats and mice after collagen implantation.
    Luttikhuizen DT; Harmsen MC; van Luyn MJ
    J Tissue Eng Regen Med; 2007; 1(5):398-405. PubMed ID: 18038434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in experimental glomerulonephritis in mice.
    Daniel C; Amann K; Hohenstein B; Bornstein P; Hugo C
    J Am Soc Nephrol; 2007 Mar; 18(3):788-98. PubMed ID: 17287428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy.
    Schroen B; Heymans S; Sharma U; Blankesteijn WM; Pokharel S; Cleutjens JP; Porter JG; Evelo CT; Duisters R; van Leeuwen RE; Janssen BJ; Debets JJ; Smits JF; Daemen MJ; Crijns HJ; Bornstein P; Pinto YM
    Circ Res; 2004 Sep; 95(5):515-22. PubMed ID: 15284191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compromised production of extracellular matrix in mice lacking secreted protein, acidic and rich in cysteine (SPARC) leads to a reduced foreign body reaction to implanted biomaterials.
    Puolakkainen P; Bradshaw AD; Kyriakides TR; Reed M; Brekken R; Wight T; Bornstein P; Ratner B; Sage EH
    Am J Pathol; 2003 Feb; 162(2):627-35. PubMed ID: 12547720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covalent modification of porous implants using extracellular matrix proteins to accelerate neovascularization.
    Williams SK; Kleinert LB; Hagen KM; Clapper DL
    J Biomed Mater Res A; 2006 Jul; 78(1):59-65. PubMed ID: 16602088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.